Loading…
Biological Activity of 1α -Hydroxycholecalciferol, A Synthetic Analog of the Hormonal form of Vitamin D3
1,25-Dihydroxycholecalciferol, the apparent active hormonal form of cholecalciferol (vitamin D3), is formed from cholecalciferol by specific and sequential hydroxylations of the sterol at carbons 25 and 1. Recently, 1α -hydroxycholecalciferol was synthesized and we report on its biological activity...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS 1973-08, Vol.70 (8), p.2248-2252 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | 1,25-Dihydroxycholecalciferol, the apparent active hormonal form of cholecalciferol (vitamin D3), is formed from cholecalciferol by specific and sequential hydroxylations of the sterol at carbons 25 and 1. Recently, 1α -hydroxycholecalciferol was synthesized and we report on its biological activity in rachitic chicks. 1α -Hydroxycholecalciferol is identical in potency to 1,25-dihydroxycholecalciferol in stimulation of intestinal calcium absorption; either sterol elicits a near maximal effect at a dose of 0.3-0.6 nmol. The time-course of action of 1α -hydroxycholecalciferol also parallels that of the active metabolite 1,25-dihydroxycholecalciferol with a maximal increase in calcium transport occurring 5-10 hr after administration of sterol to vitamin D-deficient chicks. 6.5 nmol of 1α -hydroxycholecalciferol causes a doubling in calcium absorption in only 2-3 hr, which is the most rapid physiologic response yet detected for a vitamin D-sterol. 1α -Hydroxycholecalciferol is active also in enhancing bone calcium resorption and, like 1,25-dihydroxycholecalciferol, is at least 10 times as active as cholecalciferol in mobilizing bone calcium and raising plasma calcium concentration. It is concluded that 1α -hydroxycholecalciferol represents a synthetic analog of 1,25-dihydroxycholecalciferol that can be used both to study the mechanism of action of this hormone and as a therapeutic agent in the treatment of patients with certain metabolic bone diseases. |
---|---|
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.70.8.2248 |